Geron Corp (NASDAQ:GERN)
| 1.83 Delayed Data As of 4:00pm ET |  -0.03 / -1.61%Today’s Change | 0.75 Today|||52-Week Range 2.40 | +34.56% Year-to-Date |
Latest GERN News | Press Releases
No recent news for Geron Corp.
Today’s Trading
| Previous close | 1.86 |
| Today’s open | 1.85 |
| Day’s range | 1.81 - 1.85 |
| Volume | 100,080 |
| Average volume (3 months) | 3,265,671 |
| Market cap | $600.8M |
Data as of 4:00pm ET, 10/21/2020
Growth & Valuation
| Earnings growth (last year) | -135.47% |
| Earnings growth (this year) | +30.56% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -56.85% |
| P/E ratio | NM |
| Price/Sales | 562.21 |
| Price/Book | 2.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AVROAVROBIO Inc | +0.02 | +0.13% |
| VXRTVaxart Inc | -0.11 | -2.15% |
| VBIVVBI Vaccines Inc | -0.07 | -2.87% |
| XBITXBiotech Inc | -0.45 | -2.39% |
Data as of 4:00pm ET, 10/21/2020
Financials
| Next reporting date | October 29, 2020 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $460.0K |
| Annual profit (last year) | -$68.5M |
| Net profit margin | -14,901.74% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foster City, California |
Forecasts
